Wishbone HAE
Wishbone SA · Decision date Oct 9, 2026
What did the FDA decide?
FDA recorded decision SESE for 510(k) submission K260096, titled Wishbone HAE, with a decision date of 2026-10-09. The record lists Wishbone SA of Flémalle, Belgium, as applicant and places the submission in the Dental medical specialty under product code NPM. The public notification page shows a received date of 01/13/2026. SESE denotes a substantially equivalent determination, which is a 510(k) clearance rather than premarket approval of a new device.
The available record does not describe the device's components, materials, intended use, or the specific item compared with a predicate, so the technical basis for the equivalence finding is not established here. The relationship between this submission and any earlier filing by the same applicant is also not stated in the retrieved text. Researchers should consult the full FDA decision document for those details.
No clinical performance data, labeling, or postmarket obligations appear in the retrieved material, and none are inferred.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Dental
- Decision date
- Oct 9, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260096
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Wishbone SA
- Product code
- NPM
- Decision code
- SESE
- Decision date
- Oct 9, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Bone Grafting Material, Animal Source.
- Applicant
- Wishbone SA
- Product code
- NPM
- FDA device class
- 2
FDA decision timeline
K260096 received
Application receipt date recorded by FDA.
K260096 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code NPM
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Hyundai Bioland Co., Ltd. | 510(k) clearance | Sep 25, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Wishbone SA
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Flémalle
Sources and methodology
- Original FDA record: K260096
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records